Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAR-0100A for Cognitive Enhancement in SPD
NCT01466205Phase 2Unknown
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dihydrexidine in schizotypal personality disorder (STPD). Status: unknown.
02
Drugs
dihydrexidine
03
Conditions
schizotypal personality disorder (STPD)
Beyond the preview
Go deeper on NCT01466205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466205.